MetaCap

National Vision Holdings Inc. (EYE)

NASDAQ: EYEHealth CareOphthalmic GoodsUSD

16.72-0.29 (-1.70%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

EYE stock chart

Technical analysis

Key statistics

All statistics
52-week range
14.75 – 30.02
Day range
16.59 – 17.62
Volume / Avg
1.33M / 2.14M
Beta
—

52-week range

$14.75$30.02

EYE stock today

National Vision (EYE) closed at $16.72 on Nov 20, down 1.70% (-$0.29), versus the S&P 500's 3.70% decline. Shares are 44.3% below their 52-week high of $30.02, set on Jan 15, 2026 and 13.4% above the 52-week low of $14.75, near the bottom of the past year's range. EYE is down 35.2% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 37.1%.

At 20.4x trailing earnings, National Vision trades below the peer-group median of 37.2x. Its forward P/E of 14.3x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year.

Summary generated from market data by MetaCap's automated system. Methodology

About National Vision

Company profile

National Vision Holdings, Inc., through its subsidiaries, operates as an optical retailer in the United States. The company offers eyeglasses and contact lenses, and optical accessory products; and provides eye exams through its America's Best, Eyeglass World, Vista Optical, Fred Meyer, Vista Optical military, and DiscountContacts.com. It also offers health maintenance organization and optometric services.

Industry
Ophthalmic Goods
CEO
Mr. Alexander N. Wilkes
Headquarters
Duluth, GA
Employees
13,138
IPO year
2017

Financial highlights

Full financials

In fiscal 2025, National Vision generated $1.99 billion in revenue, up 9.0% from fiscal 2024, its 3rd consecutive year of revenue growth. Net income was $29.6 million, for a net margin of 1.5% versus a median of 2.1% in the prior 5 years. Gross margin was 58.8% (up from 58.1%) and operating margin 3.0%.

National Vision annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$1.99B$1.82B$1.76B$1.64B$2.08B
Growth+9.00%+3.81%+6.79%-20.91%+21.48%
Net income$29.60M$-28.50M$-65.90M$42.12M$128.24M
EPS (diluted)$0.37$-0.36$-0.84$0.52$1.43

Analyst forecast

Forecast

Consensus (11 analysts)

buy

Avg. price target

$27.00+61.48%

  • Strong buy 1
  • Buy 7
  • Hold 3
  • Sell 0
  • Strong sell 0

Target range

Low $20.00High $35.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 12, 2026
EPS actual vs est.
$0.23 vs $0.06
Surprise
+283.33%

EYE news

All EYE news

National Vision peers

Health Care sector
EYE peer companies
CompanyPrice% ChgMarket capCompare
STAASTAAR Surgical Company24.22-3.24%$1.22Bvs EYE
RXSTRxSight Inc.4.47-3.04%$187.42Mvs EYE
LUCYInnovative Eyewear Inc.0.7025-0.07%$6.12Mvs EYE
WRBYWarby Parker Inc. Class A23.12-4.19%$2.87Bvs EYE
BLCOBausch + Lomb Corporation19.38-6.33%$6.93Bvs EYE
COOThe Cooper Companies Inc.58.88-2.40%$11.20Bvs EYE
ALCAlcon Inc.74.31-0.26%$35.70Bvs EYE

Indexes, lists and sector

National Vision stock FAQ

What is National Vision's stock price today?

EYE last traded at $16.72 as of Nov 20, 4:00 PM EST, down 1.70% on the day. Prices are delayed at least 15 minutes.

What is EYE's P/E ratio?

EYE trades at a trailing P/E ratio of 20.39 and a forward P/E of 14.31, compared with a median of 37.2 for its closest peers.

Who is National Vision's CEO?

Mr. Alexander N. Wilkes is the chief executive officer of National Vision Holdings Inc., which has about 13,138 employees.

What is the EYE 52-week high?

The 52-week high for EYE is $30.02 and the 52-week low is $14.75. The stock is currently 44.3% below its high.

Compare EYE